Zoetis Inc at KeyBanc Healthcare Forum Transcript
Okay. Good morning. My name is Steve Dechert with KeyBanc Capital Markets. I'm on the healthcare tech team. And today, we have Kristin Peck, CEO of Zoetis. Before we get going, if anyone would like to ask a question, you can do so in the webinar chat.
Questions & Answers
But Kristin, just to kick things off, so you're guiding to 3.5% organic constant currency growth this year after doing 6% in 2025. Could you walk us through the puts and takes of the guidance? And which segments are expected to lead that growth?
Sure. Well, first, thanks for having me. It is great to be back. As we look at our guidance of a 3% to 5% organic operational revenue growth, what we'd say is, as always, it's really the diversity of our portfolio that will lead that. We don't think there's sort of one single factor that will drive that. As you think
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

